You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 7, August 21, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Corticosteroids and Septic Shock

Edward Abraham, MD; Timothy Evans, MD

JAMA. 2002;288:886-887.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The use of corticosteroid therapy in patients with sepsis and septic shock has a long and controversial history. The first study suggesting that steroids could prove beneficial in this patient population was published in 1951,1 and the results of more than 50 clinical investigations exploring this hypothesis have been published since.2-3 Early reports4 suggested that survival was improved; but subsequent large, randomized studies and meta-analyses failed to show a mortality benefit and have even indicated that steroid therapy may be harmful.2-3,5

Despite this historical burden, several small studies have suggested recently that glucocorticoids might afford clinical benefit to rigorously characterize groups of patients with infection complicated by hypotension unresponsive to fluids and by organ dysfunction.6-7 In particular, the high incidence of acquired adrenal insufficiency, or lack of adrenal reserve, in such critically ill patients has provided a strong rationale for the prolonged administration of . . . [Full Text of this Article]

Author Affiliations: Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver (Dr Abraham) and Unit of Critical Care, Imperial College of Science, Technology & Medicine, Royal Brompton Hospital, London, England (Dr Evans).


RELATED ARTICLE

Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
Djillali Annane, Véronique Sébille, Claire Charpentier, Pierre-Edouard Bollaert, Bruno François, Jean-Michel Korach, Gilles Capellier, Yves Cohen, Elie Azoulay, Gilles Troché, Philippe Chaumet-Riffaut, and Eric Bellissant
JAMA. 2002;288(7):862-871.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Should We Use Etomidate as an Induction Agent for Endotracheal Intubation in Patients With Septic Shock?: A Critical Appraisal
Jackson
Chest 2005;127:1031-1038.
ABSTRACT | FULL TEXT  

Management of Infectious Complications in the Hematopoietic Stem Cell Transplant Recipient
Nichols
J Intensive Care Med 2003;18:295-312.
ABSTRACT  

Steroids for Septic Shock: Back From the Dead? (Con)
Sessler
Chest 2003;123:482S-489S.
ABSTRACT | FULL TEXT  

The Pathophysiology and Treatment of Sepsis
Hotchkiss and Karl
NEJM 2003;348:138-150.
FULL TEXT  

Corticosteroids for Everyone with Meningitis?
Tunkel and Scheld
NEJM 2002;347:1613-1615.
FULL TEXT  

Low-Dose Steroids in Septic Shock
JWatch General 2002;2002:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.